Insights into complex regulation of human respiration
Respiration, a vital automatic process crucial for life, is finely regulated through a series of complex mechanisms involving various parts of the nervous system and ... Read More
Understanding Hantavirus : Transmission, symptoms, and prevention
Hantavirus is a severe and sometimes fatal respiratory disease transmitted to humans through contact with infected rodents, primarily deer mice. The virus belongs to the ... Read More
Wave Life Sciences, GSK partner on oligonucleotide-based gene therapies
Wave Life Sciences and GSK have forged a partnership to discover and develop oligonucleotide therapeutics, focusing on new genetic targets, for respiratory diseases. The discovery ... Read More
Lupin Limited gets approval for Luforbec 100/6 µg pMDI in UK
Lupin Limited said that its subsidiary Lupin Healthcare (UK) has secured approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for Luforbec (beclometasone dipropionate/formoterol ... Read More
Tenzing to acquire clinical-stage pharma company Reviva Pharmaceuticals
Tenzing Acquisition has agreed to acquire Reviva Pharmaceuticals, a California-based clinical-stage pharma company, focused on developing therapies for addressing unmet medical needs in the areas ... Read More
China’s CF PharmTech raises $50m in Series F round for inhalation products
CF PharmTech, a Chinese pharma company, has raised $50 million in a Series F financing round to accelerate the commercialization of its inhalation products. The ... Read More
Incyte to launch ruxolitinib coronavirus clinical trial in US
Ruxolitinib coronavirus clinical trial : Incyte revealed that it is working with the US Food and Drug Administration (FDA) to launch the phase 3 RUXCOVID ... Read More
AstraZeneca taps into Gatehouse Bio’s sRNAlytics AI platform for drug discovery
US biodata company Gatehouse Bio is joining forces with pharma giant AstraZeneca to accelerate the discovery of new drugs for respiratory and cardiovascular diseases using ... Read More
Roivant Sciences launches Respivant Sciences to advance treatments for respiratory diseases
Roivant Sciences has launched a new biopharma company, Respivant Sciences, to focus on cutting-edge treatments for severe respiratory conditions. The newly established Respivant Sciences will ... Read More